EUVIMEDObjevte EUVIMED
Crossref

PhOxi-seq Detects Enzyme-Dependent m 2 G in Multiple RNA Types

Marie Klimontova, Kimberley Chung Kim Chung, Han Zhang, Tony Kouzarides, Andrew J Bannister, Ryan Hili iD

ACS Chemical Biology · 2024

DOI: 10.1021/acschembio.4c00548 ↗

At a glance

Journal article in ACS Chemical Biology, 2024. Written by Marie Klimontova and 5 co-authors. Institution: The Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge CB2 1QN, United Kingdom. Major MEDLINE topics: RNA. 25 references. Funded by: Wellcome Trust, Ontario Ministry of Research and Innovation, Canada Foundation for Innovation.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

In recent years, RNA-modifying enzymes have gained significant attention due to their impact on critical RNA-based processes and, consequently, human pathology. However, identifying sites of modifications throughout the transcriptome remains challenging largely due to the lack of accurate and sensitive detection technologies. Recently, we described PhOxi-seq as a method capable of confirming known sites of m2G within abundant classes of RNA, namely, purified rRNA and purified tRNA. Here, we further explore the selectivity of PhOxi-seq and describe an optimized PhOxi-seq workflow, coupled to a novel bioinformatic pipeline, that is capable of detecting enzyme-dependent m2G sites throughout the transcriptome. In this way, we generated a database of potential THUMPD3-dependent m2G sites in multiple RNA classes within a human cancer cell line and further identify potential non-THUMPD3 controlled m2G sites. These potential sites should serve as the basis for further confirmation studies for m2G within the human transcriptome.

Subjects

MeSH terms (MEDLINE)

RNAHumansCell Line, TumorTranscriptomeSequence Analysis, RNAComputational BiologyRNA, TransferRNA Processing, Post-Transcriptional

Substances

RNARNA, Transfer

Authors and institutions

  • The Gurdon Institute and Department of Pathology, University of Cambridge, Cambridge CB2 1QN, United Kingdom.
  • STORM Therapeutics Ltd., Babraham Research Campus, Cambridge CB22 3AT, United Kingdom.
  • Department of Chemistry and Centre for Research on Biomolecular Interactions, York University, Toronto, Ontario M3J 1P3, Canada.
  • Milner Therapeutics Institute, University of Cambridge, Cambridge CB2 0AW, United Kingdom.

ORCID profiles: Ryan Hili

Funding

  • Wellcome Trust
  • Ontario Ministry of Research and Innovation
  • Canada Foundation for Innovation
  • York University
  • Natural Sciences and Engineering Research Council of Canada
  • Cancer Research UK
  • Storm Therapeutics

Cite

APA

Klimontova, M., Chung, K. C. K., Zhang, H., Kouzarides, T., Bannister, A. J., & Hili, R. (2024). PhOxi-seq Detects Enzyme-Dependent m 2 G in Multiple RNA Types. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00548

Vancouver

Klimontova M, Chung KCK, Zhang H, Kouzarides T, Bannister AJ, Hili R. PhOxi-seq Detects Enzyme-Dependent m 2 G in Multiple RNA Types. ACS Chemical Biology. 2024. doi:10.1021/acschembio.4c00548

BibTeX
@article{Klimontova2024,
  author = {Klimontova, Marie and Chung, Kimberley Chung Kim and Zhang, Han and Kouzarides, Tony and Bannister, Andrew J and Hili, Ryan},
  title = {PhOxi-seq Detects Enzyme-Dependent m 2 G in Multiple RNA Types},
  journal = {ACS Chemical Biology},
  year = {2024},
  doi = {10.1021/acschembio.4c00548}
}
Start for free →